Brief: Bellus Health Says First Patient Enrolled In Mid-Stage Study Of Chronic Cough Treatment

BELLUS Health

30/07/2019 13:11

July 30 (Reuters) - BELLUS Health Inc  BLU.TO :
    * BELLUS HEALTH ANNOUNCES FIRST PATIENT ENROLLED IN PHASE 2
STUDY
OF BLU-5937 FOR THE TREATMENT OF REFRACTORY CHRONIC COUGH &
PURSUIT OF SECOND INDICATION IN CHRONIC PRURITUS
    * BELLUS HEALTH INC - PHASE 2 STUDY WILL EVALUATE EFFICACY
OF
BLU-5937 AND IS EXPECTED TO ADD TO PHASE 1 EVIDENCE SHOWING
LITTLE TO NO IMPACT ON TASTE
    * BELLUS HEALTH INC - TOP-LINE RESULTS FROM PHASE 2 STUDY
EXPECTED
MID-2020
    * BELLUS HEALTH INC - PHASE 2 STUDY IN CHRONIC PRURITUS
EXPECTED
TO BEGIN IN 2020

Source text for Eikon:  ID:nBw8YJWQ1a 
Further company coverage:  BLU.TO 

 ((Reuters.Briefs@thomsonreuters.com;))